BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2849606)

  • 1. Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer.
    Splinter TA; Carney DN; Teeling M; Oosterom R
    J Cancer Res Clin Oncol; 1988; 114(6):641-3. PubMed ID: 2849606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.
    Splinter TA; Carney DN; Teeling M; Peake MD; Kho GS; Oosterom R; Cooper EH
    J Cancer Res Clin Oncol; 1989; 115(4):400-1. PubMed ID: 2547802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
    Cooper EH; Splinter TA; Brown DA; Muers MF; Peake MD; Pearson SL
    Br J Cancer; 1985 Sep; 52(3):333-8. PubMed ID: 2994704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
    Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
    Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific enolase during chemotherapy of small cell lung cancer.
    Buamah PK; Drake SR; Smedley HM; Bodger WA; Skillen AW
    J Surg Oncol; 1990 May; 44(1):1-4. PubMed ID: 2160568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
    Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP
    Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-specific enolase as a guide to the treatment of small cell lung cancer.
    Splinter TA; Cooper EH; Kho GS; Oosterom R; Peake MD
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):171-6. PubMed ID: 2832176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
    Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
    Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
    Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic value of serum neuron specific enolase detection in small cell lung cancer].
    Jin B; Zhao L; Zhou C
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):722-4. PubMed ID: 11930699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
    Jørgensen LG; Hansen HH; Cooper EH
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study].
    Emin Erbaycu A; Gunduz A; Batum O; Zeren Ucar Z; Tuksavul F; Zeki Guclu S
    Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1992 Sep; 66(3):594-8. PubMed ID: 1325829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
    Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
    Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C
    Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.
    Ebert W; Muley T; Trainer C; Dienemann H; Drings P
    Anticancer Res; 2002; 22(2B):1083-9. PubMed ID: 12168905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung.
    Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
    Gan; 1983 Apr; 74(2):219-25. PubMed ID: 6305752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.